Skip to main content
Fig. 7 | BMC Immunology

Fig. 7

From: Identification of BTK as an immune-related biomarker for Hashimoto’s thyroiditis by integrated bioinformatic analysis

Fig. 7

Validation of the transcript levels of BTK and CD19. (A) The relative expression of BTK mRNA in the PBMCs from HT patients (n = 24) and normal controls (n = 20). (B) The relative expression of CD19 mRNA in the PBMCs from HT patients (n = 24) and normal controls (n = 20). Each data point represents an individual subject, and the horizontal lines show the mean. *p < 0.05, NS: no significance

Back to article page